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ABR: Auditory Brainstem Response  
ADA: adenosine deaminase  
ADK: adenosine kinase 
AHCY: S-adenosylhomocysteine hydrolase  
ARHL: age-related hearing loss 
BHMT: betaine homocysteine methyltransferase 
CBS: cystathionine β-synthase 
DAB: 3,3’-diaminobenzidine 
EDTA: ethylenediaminetetraacetic acid 
GSH: glutathione reduced form 
GSSG: glutathione oxidized form 
Hcy: homocysteine 
HL: hearing loss 
HPLC: high performance liquid chromatograply 
H&E: haematoxylin and eosin 
MAT: methionine adenosyltransferase 
MTHFR: methylenetetrahydrofolate reductase 
MTR: methionine syntase 
3-NT: 3-nitrotyrosine 
PBS: phosphate buffered saline 
PFA: paraformaldehyde 
pHcy: plasma homocysteine 
RT-qPCR: real-time reverse transcriptase polymerase chain reaction. 












Nutritional imbalance is emerging as a causative factor of hearing loss (HL). 
Epidemiological studies have linked HL to elevated plasma homocysteine (pHcy) and 
folate deficiency, and showed that folate supplementation lowers pHcy levels 
potentially ameliorating age-related HL. The purpose of this study was to address the 
potential impact of folate deficiency in HL and to unveil the underlying mechanisms. 
For this purpose, two-month old C57BL/6J-mice (Animalia Chordata Mus musculus) 
were randomly divided in two groups (n=65 each) that were fed folate-deficient or 
standard diets for 8 weeks. HPLC analysis demonstrated 7-fold decline in serum folate 
and 3-fold increase in pHcy levels. Auditory brainstem recordings showed that only 
folate-deficient mice exhibited severe HL and cochlear TUNEL+-apoptotic cells. RT-
qPCR and Western-blotting showed reduced levels of enzymes involved in Hcy 
production and recycling, together with 30% increased protein homocysteinylation. 
Redox stress was evidenced by decreased expression of Cat, Gpx4 and Gss genes, 
increased levels of the proteins MnSOD and the NOX-complex adaptor p22phox, and 
elevated concentrations of glutathione species. Altogether, our findings show for the 
first time that the relationship between folate-induced hyperhomocysteinemia and 
premature HL involves impairment of cochlear Hcy metabolism and associated 
oxidative stress. 
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Moderate-to-profound hearing loss affects over 360 million people worldwide 
according to recent World Health Organization data. Its incidence varies in each 
population segment, being approximately 10% in children, rising to 30% in adults over 
65-years (age-related hearing loss, ARHL) and further increasing with age (1, 2). It is 
caused by a combination of genetic and environmental factors and has a tremendous 
impact in the quality of life of the elderly (2, 3). In contrast with congenital deafness, 
little is known about the genetic factors that contribute to ARHL, most of the available 
information deriving from the study of mouse models (4, 5). Regarding environmental 
factors, noise and ototoxic drugs are among the well-known stressors inducing early 
hearing loss (6, 7), but a few reports have suggested recently a role for the nutritional 
status in premature hearing impairment. Indeed, decreased levels of essential nutrients, 
such as several vitamins, have been shown to correlate with hearing loss (8-14). Among 
micronutrients, reduced folic acid concentrations have been found in ARHL and sudden 
sensorineural hearing loss, this decrease correlating with either reduced vitamin B12 
status (11, 12) or increased homocysteine (Hcy) levels (13). Accumulating evidence 
from epidemiological research has shown the association between atherosclerosis in the 
inner ear and poor hearing, as well as the relationship between risk factors of vascular 
disease and ARHL (15-17). The intimate relationship between Hcy, an independent risk 
factor for cardiovascular disease, and folic acid metabolism provides the basis by which 
supplementation with the vitamin lowers plasma Hcy levels (18), an intervention that 
has been reported to ameliorate ARHL in a randomized trial (19).  
Hcy constitutes a metabolic branchpoint linking the methionine and folate cycles 
and the trans-sulfuration pathway (Figure 1A). Hcy remethylation is catalyzed by either 
cobalamine-dependent methionine syntase (MTR) or betaine homocysteine 
methyltransferase (BHMT), enzymes that use 5’-methyltetrahydrofolate and betaine as 
methyl donors, respectively (20). Both reactions generate methionine that is in turn used 
to synthesize S-adenosylmethionine, the main methyl donor for cellular 
transmethylations. Donation of the methyl group renders S-adenosylhomocysteine that 
is hydrolyzed by S-adenosylhomocysteine hydrolase (AHCY) to Hcy and adenosine in 
a reversible reaction. Elimination of Hcy takes place by conjugation with serine in a B6-
dependent reaction catalyzed by cystathionine β-synthase (CBS), or by export into the 
plasma. The correct function of the pathway depends on a continuous supply of 5’-
methyltetrahydrofolate that is recycled in the folate cycle, where 
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methylenetetrahydrofolate reductase (MTHFR) exerts a key role. Epidemiological 
studies have analyzed the putative relationship of the MTHFR C677T mutation with 
hearing loss with contradictory results (21-23). Animal models have also generated data 
that, collectively taken, support a central role for Hcy metabolism in hearing 
pathophysiology. For example, Cbs+/- mutant mice have increased hearing thresholds, 
high concentrations of Hcy in the stria vascularis and the spiral ligament, oxidative 
stress and reduction of vessel density, effects that were prevented by the administration 
of folic acid in the drinking water (24). Hearing impairment has been also described in 
Connexin 30 (Cx30-/-) null mice, where the stria vascularis exhibited down- and up-
regulation of Bhmt and Ahcy expression, respectively, and elevated levels of Hcy 
immunostaining (25).  
Altogether human epidemiology and mouse genetic data reinforce the hypothesis 
that folic acid deficiency and Hcy metabolism play an important role in hearing 
disorders, although the mechanisms by which cochlear function is affected remain 
poorly understood. Here, we have used a rodent model of folic acid deficiency (26, 27) 
to show that a reduced intake of this essential vitamin causes cochlear impairment of 
Hcy metabolism, oxidative stress, severe cellular damage and apoptotic cell death 


















MATERIALS AND METHODS 
Mouse handling and experimental design 
Two month-old C75BL/6J female mice were purchased from Harlan Interfauna 
Ibérica S.A. (Barcelona, Spain) and housed under standard conditions. The C57BL/6J 
mouse strain is a well-characterized model of progressive HL due to the Ahl alleles 
present in its genome that shows ARHL from the age of six-months onward (28, 29). 
Mice were randomly divided into two experimental groups (n=65 each) that were fed 
different types of diets ad libitum for 8 weeks. The normal folate group (NF) received a 
maintenance diet containing standard folate levels (A04/A04C/R04, Scientific Animal 
Food & Engineering, Panlab, Cornellá de Llobregat, Spain), whereas the folate-
deficient group (FD) received a folate-depleted diet (folic acid ≤ 0.1-0.2 mg/kg) as 
previously described (26, 27). At least 6 different mouse cohorts including both 
experimental groups were studied independently. All experiments were approved by the 
CSIC Bioethics Committee and carried out in full accordance with the guidelines of the 
European Community (2010/63/EU) and the Spanish regulations (RD 53/2013) for the 
use of laboratory animals. Additionally, certain experiments required the use of the 
Bhmt-/- null mice previously described (30), as specified below.  
Hearing assessment 
Hearing was evaluated by Auditory Brainstem Response (ABR) analysis to 
broadband click and 8, 16, 20, 28 and 40 kHz pure tone frequencies recorded at an 
intensity range from 90 to 20 dB SPL in 5-10 dB steps, as previously reported (31-33). 
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg). The 
electrical responses were amplified and averaged to determine hearing thresholds for 
each stimulus. Peak and interpeak latencies were analyzed at 15-20 dB SPL above 
hearing threshold after click stimulation. The FD group showed either moderate or 
profound hearing loss in two well-defined populations. Therefore, further 
determinations in the FD group were restricted to those animals exhibiting profound 
hearing loss. 
Blood and tissue extraction  
Mice were sacrificed by CO2 asphyxiation for fresh tissue removal, and the 
isolated tissues were immediately frozen in liquid nitrogen for protein or RNA 
extraction. Blood samples were collected by cardiac puncture and directly placed in 
either regular or heparin (Laboratorios Farmacéuticos Rovi, Madrid, Spain) coated 
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tubes, centrifuged at 2500 xg for 10 minutes, and the respective serum and plasma 
fractions isolated and stored at -80ºC until use.  
For histological analysis, mice were injected with a pentobarbital overdose and 
perfused with cold PBS and 4% (v/v) paraformaldehyde (PFA; Merck, Darmstadt, 
Germany). Cochleae were then dissected out from the temporal bone as previously 
described (34, 35). Isolated tissues were immediately frozen in liquid nitrogen or fixed 
for immunohistochemistry studies. Fixation was carried out overnight in 4% (v/v) PFA 
at 4ªC followed by decalcification with EDTA (Sigma-Aldrich, Tres Cantos, Madrid, 
Spain) for 10 days (31, 32). Decalcified samples were dehydrated and embedded in 
paraffin wax (Panreac Química, Castellar del Vallés, Barcelona, Spain) or cryoprotected 
in sucrose, embedded in a sucrose/gelatin solution and frozen in isopentane at -80ºC as 
previously described (36).  
Cochlear Morphology and Immunohistochemistry 
Cochlear cytoarchitecture was evaluated using representative paraffin sections (7 
μm thick) stained with haematoxylin-eosin (H&E; Sigma-Aldrich) and Masson´s 
Trichrome (Sigma-Aldrich). Phalloidin histochemistry was performed on frozen 
sections using Alexa-488 conjugated phalloidin (1:100 v/v; Molecular Probes, Eugene, 
OR, USA). For paraffin immunohistochemistry, slides were dewaxed, rehydrated and 
the endogenous peroxidase inactivated for 20 minutes with 3% (v/v) hydrogen peroxide 
(Merck). For immunohistofluorescence, cryostat frozen sections (15 µm) were prepared 
using Cryocut 1900 (Leica Microsystems, Dearfield, IL, USA). All slides were 
permeabilized in 0.05% (v/v) Triton-X-100 (Calbiochem, LaJolla, CA, USA) in PBS 
(T-PBS) and non-specific tissue-binding sites were blocked for 40 minutes using 5% 
(v/v) normal rabbit or donkey serum (Sigma-Aldrich) in PBS. Samples were incubated 
with the primary antibodies overnight at 4ºC, washed with T-PBS and incubated with 
the corresponding secondary antibody for 2 hours at room temperature (Table 1). Slides 
were then washed with T-PBS and covered with a tertiary extrAvidin® peroxidase-
conjugated antibody for 90 minutes (1:200 v/v; Sigma-Aldrich). Immunodetection was 
carried out with 3,3’-diaminobenzidine (DAB; Sigma-Aldrich). When indicated, 
sections were dehydrated and mounted with Entellan (Merck) or Prolong Gold with 
DAPI (Invitrogen, Carlsbad, CA, USA). All brightfield images were obtained using an 
Olympus DP70 digital camera mounted on a Zeiss microscope. Immunofluorescence 
images were acquired in a confocal microscope (Leica TCS SP2, Wetzlar, Germany). 
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Photomicrograph acquisition and densitometry for 3-nitrotyrosine (3-NT) 
quantification were performed as reported, using a minimum of four animals per group 
(32). Freehand-delimited areas for the stria vascularis and the cochlear ganglion were 
used for the optical density estimation using ImageJ software v1.43m. Three 
consecutive serial slides were studied and, for each section, at least two pictures per 
structure were taken. The same procedure was carried out for myelin P0 and Kir4.1 
immunohistochemistry quantification. The relative intensity/area ratio of the cochlear 
ganglion was performed on paraffin sections stained with H&E using ImageJ software. 
Every fifth slide was analyzed so that at least four representative sections for each 
animal and cochlear region were included.  
Metabolite determinations. 
 Total pHcy was determined after derivatization using the Reagent kit for the 
HPLC analysis of Hcy in plasma/serum (Chromsystems Instruments & Chemicals 
GmbH, Munich, Germany). Derivatized samples (50 µl) were injected into the HPLC 
column and fluorescence measured at 515 nm after excitation at 385 nm. 
 Plasma vitamin B6 levels were measured using a commercial kit (Chromsystems 
Instruments & Chemicals GmbH) and HPLC analysis coupled to fluorescence detection 
following manufacturer’s instructions. 
 Total serum folate was determined using the microbiological method described 
by Horne and Patterson (37) with the modifications introduced by Tamura (38). 
 Reduced (GSH) and oxidized glutathione (GSSG) levels were measured by the 
method of Tietze as modified by Rahman et al. (39). For this purpose, two cochleae 
were homogenized in 0.1 M potassium phosphate buffer pH 7.5, containing 5 mM 
EDTA and 0.6% (w/v) sulfosalicylic acid (250 μl), centrifuged at 8000 xg 10 min at 4ºC 
and the corresponding extract used for GSH (1:10 v/v) and GSSG (1:2 v/v) 
determinations. 
Protein extraction and Western blotting  
 Whole cochlear protein was prepared as previously reported (34, 40). Protein 
concentrations were measured using the Pierce BCA Protein assay kit (Thermo 
Scientific, Rockford, IL, USA) and bovine serum albumin as standard. Samples (200 
μg) were loaded in 10% SDS-PAGE gels and electrotransferred for incubation with the 
corresponding dilutions of primary and secondary antibodies for 1 hour as specified in 
Table 1. Signals were developed using Western Lightning ECL (Perkin Elmer, 
Waltham, MA, USA). Blots were subjected to densitometric scanning using ImageJ and 
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the values normalized against α-tubulin or β-actin signals. Mean values for the NF 
group were considered 100%.  
Real-time RT-PCR 
 Total cochlear RNA was isolated from NF and FD mice using RNeasy kit 
(Qiagen, Hilden, Germany), and the quality and quantity determined 
spectrophotometrically and by automated electrophoretogram on a Bioanalyzer 2100 
(Agilent Technologies, Santa Clara, CA, USA). Reverse transcription and PCR were 
done as previously described using 1.25 μg of total RNA as template and the High 
Capacity Archive kit (Applied Biosystems, Foster City, CA, USA) (41). cDNAs (10 ng) 
were amplified in triplicate using gene specific primers (Table 2) and Power SYBR 
Green PCR Master Mix (Applied Biosystems) or TaqMan probes (Cat, Foxm1, Foxp3, 
Gap43, Gclc, Gpx1, Gpx4, Gsr, Gss, Mef2a, Mef2d), using the ABI 7900HT Real-Time 
PCR system (Applied Biosystems). Primers for Cbs and Adk amplification were 
designed to allow amplification of the two splicing forms of each gene reported to date. 
Fluorescent signals were collected after each extension step, and the curves analyzed 
with SDS 2.2.2 software. Relative expression ratios were normalized to the geometric 
mean of the Rn18s or the Rplp0 genes. Experimental efficiencies were calculated for 
each transcript and used to obtain the fold changes according to Pfaffl et al. (42).  
TUNEL assay 
 The presence of apoptotic cells was evaluated in cochleae using the ApopTag 
Plus Peroxidase In Situ Apoptosis Detection kit (S7100; Millipore Iberica S.A.U., 
Madrid, Spain) for TUNEL assay, according to manufacturer’s instructions. Briefly, 
samples were fixed in PFA 1% (v/v) for 10 minutes at room temperature, washed twice 
in PBS and post-fixed at -20ºC in ethanol:acetic acid (2:1, v/v) for 5 minutes. Slides 
were then washed, endogenous peroxidase was blocked with hydrogen peroxide (5%, 
v/v 20 minutes), washed again and the equilibration buffer was added for 10 minutes. 
Next, samples were incubated at 37ºC for 1 hour with terminal deoxynucleotidyl 
transferase (TdT), and the reaction stopped and further incubated using the 
digoxigenin/anti-digoxigenin antibody system. The final reaction was monitored with a 
microscope using DAB as the chromogen. Afterwards, samples were dehydrated and 
mounted with Entellan (Merck). DNase I treated normal cochleae and rat post-weaning 
mammary gland tissue (S7115; Millipore) were used as positive controls, whereas 
negative controls were obtained by omitting the TdT enzyme. The number of TUNEL-
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positive cells was evaluated as described above in four sections per animal (n=6 mice 
per group) and the resulting counts averaged for comparison. 
Statistical analysis 
SPSS v 19.0 software package (SPSS, Chicago, IL, USA) and GraphPad Prism v 
5.0 (GraphPad Software, San Diego, CA, USA) were used for statistical analysis. 
Statistical significance was determined by Student’s t-test for unpaired samples between 
NF and FD groups. All results are expressed as the mean ± standard error of the mean 





























Plasma concentrations of selected metabolites were measured in mice receiving 
normal (NF) or folate-deficient (FD) diets in order to assess the effect of the treatment 
(Figure 1B). As expected, a severe reduction in serum folate levels (∼7 fold) was 
observed in the FD group as compared to the NF group. Additionally, total pHcy 
concentrations were elevated (∼3 fold) in the FD group, whereas plasma vitamin B6 
levels were similar in both dietary groups. Hence, the diet was effective in causing 
systemic folate deficiency and hyperhomocysteinemia. 
Folate deficient mice show early signs of severe sensorineural hearing loss. 
Mice in the NF group had on average, normal hearing, whereas animals in the 
FD group had moderate (34%) or profound (66%) hearing loss; only the latter group 
was further studied and referred to as FD (Figure 2A-2C). An average increase of 45 dB 
SPL in ABR thresholds was found in FD mice when compared to the NF group in 
response to click stimuli. Accordingly, there was a significant increase in hearing 
thresholds at all studied frequencies, although the effect was more acute at high (50 dB 
SPL threshold shift) than at low frequencies (20 dB SPL threshold shift)  (Figure 2C). 
Click ABR wave analysis revealed a significant delay in the latency of wave I in FD 
mice when compared to the NF group (Figure 2D), as well as a dramatic reduction of 
the amplitude of wave I (Figure S1A). No further differences were observed in ABR 
interpeak latencies (I-II, II-IV and I-IV) (Figure S1B) and the wave IV latency-intensity 
function when these parameters were measure at intensities of 20 dB SPL above 
threshold. However, a progressive decrease in the wave IV amplitude-intensity ratio 
was observed in the FD mice group (Figure S1C and S1D).  
Folate deficient mice show aberrant cochlear cytoarchitecture and altered 
expression of cell-type markers. 
Cochlear architecture differed between groups, with cellular loss in the basal 
turn seen in the FD mice, when compared to that in the NF group (Figures 3 and 4). The 
structure of the organ of Corti in the NF mice remained normal along all cochlear turns 
(Figure 3A, a-e). In contrast, the cochlea of FD mice showed a flat cochlear epithelium 
in the basal turn (Figure 3A, f-j). TUNEL-positive cells were evident in the organ of 
Corti and stria vascularis in the middle-turn of the FD cochlea, but not in the NF (Figure 
3B and 3C). At the time studied, apoptotic cells were not observed in the flat basal turn 
or in the normal apex (data not shown). Additionally, other cellular populations were 
affected in the basal and middle turns of the cochlea of FD mice when compared to the 
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NF (Figure 4). Cellular aberrations included loss of type IV fibrocytes (compare Figure 
4A and 4B with 4J and 4K) and a 33% reduction of ganglionar density and myelin P0 
levels (p<0.001; compare Figure 4D and 4E with 4M and 4N and quantification in 4F, 
4I and 4L). Myelin P0 levels remained unchanged for both dietary groups from the 
middle turn towards the apex (Figure 4L). Disorganization of the striatal capillaries and 
accumulation of melanin granules were also observed in 5 out of 9 mice of the FD 
group studied, in contrast, none of the NF group mice showed this phenotype (compare 
Figure 4G and 4H with 4P and 4Q; quantification in 4O and 4R). Kir4.1 levels did not 
show evident differences between the dietary groups (p>0.05; compare Figure 4G’ and 
4H’ with 4P’ and 4Q’). Furthermore, levels of genes expressed in the organ of Corti 
were analyzed (Figure S1E). Mef2a and Mef2d showed a small but statistically 
significant decrease in the FD group as compared to the NF, Foxp3 levels were 
significantly increased (p<0.05) and there were no differences in Gap43 and Foxm1 
levels.  
Cochlear homocysteine metabolism showed specific expression features. 
Systemic changes in folate and Hcy levels may reflect alterations in their 
cochlear metabolism, which has not been studied previously. Therefore, real-time RT-
PCR (RT-qPCR) assays were carried out using cochleae of mice in the NF group to 
define the control expression pattern. (Figure 5A). Normalization of the results using 
the Rn18s housekeeping gene, and comparison of the calculated levels utilizing Mat1a 
data as reference, allowed identification of three transcript categories: 1) including 
Mat2a, Mat2b, Ahcy and Adk with levels >20-fold larger than those of Mat1a; 2) with 
intermediate expression levels (8-fold over Mat1a), comprising Bhmt and Mtr; and 3) 
with low expression levels of similar magnitude, integrated by Mat1a, Ada, Cbs and 
Bhmt2. These results confirmed the expected extrahepatic expression pattern, except for 
Bhmt and Mtr genes.  
The corresponding proteins were detected by Western blotting, although 
differences in mobility (10-15 kDa) were found for BHMT and AHCY bands as 
compared to samples of liver origin (Figure 5B-D). In cochlear extracts, anti-BHMT 
and anti-AHCY detected proteins with calculated molecular masses of 68 and 58 kDa, 
respectively. In contrast, only a band of the expected mobility (∼45 kDa) was visible 
when using hepatoma H35 cytosols, even when larger amounts of extracts or film 
overexposure were utilized. The specificity of the BHMT band was demonstrated by the 
lack of signal observed with either preimmune rabbit serum or cochlear extracts 
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obtained from Bhmt-/- null mice (Figure 5B and 5C). Again, the data demonstrate 
specific features of Hcy metabolism in the cochlea. 
Folate deficiency induced impairment of cochlear homocysteine 
metabolism. 
Systemic changes in folate and Hcy levels may reflect alterations in this part of 
cochlear metabolism. Therefore, RT-qPCR assays were carried out to analyze the 
putative changes induced by folate deficiency (Figure 6). The mRNA levels of enzymes 
involved in Hcy production (Ahcy) and remethylation (Bhmt and Mtr) reduced their 
expression in FD mice (30-50%), as compared to NF animals. In contrast, mRNA levels 
of enzymes involved in elimination of S-adenosylhomocysteine products showed no 
change (Cbs and Adk), or a tendency to increase (Ada; p= 0.08). In addition, no 
significant alterations in mRNA levels for Mat subunits were detected, neither were 
alterations detected for Bhmt2. Therefore, expression changes induced by folate 
deficiency were directed towards reduction of Hcy production and to favor its 
elimination to the plasma or through the trans-sulfuration pathway.  
 Cochlear expression levels however may not reflect the actual protein levels that 
were analyzed by Western blotting. Decreased protein levels were found in the FD 
group, as compared to NF samples, for the AHCY 58 kDa band (∼40%), the double 
band ∼60-65 kDa corresponding to CBS isoenzymes (∼70%), and the BHMT 68 kDa 
band (∼60%)(Figure 7A-C). In contrast, ADK (41 kDa) showed no change, whereas 
increased signals were found for the 138 kDa MTR band (∼40%) and the 41 kDa ADA 
protein in FD cochleae (Figure 7D-F). This last protein gave no signal in NF samples. 
Again, the results suggest an effort to reduce Hcy production and towards elimination to 
the plasma. However, the combined effects on expression and protein levels in FD mice 
may not be enough to avoid the increase in intracellular Hcy levels. A consequence of 
such an intracellular enhancement of Hcy could be protein homocysteinylation, a 
protein modification that can be followed by Western blotting using total cochlear 
extracts and anti-Hcy (Figure 7G). The results indicated a 50% increase in 
immunostaining of FD cochlear proteins, as compared to NF extracts, indicative of 
cochlear hyperhomocysteinemia.  
Folate deficient mice showed oxidative imbalance in the cochlea.  
 Hearing loss has been previously associated to redox imbalance, hence we next 
studied the putative effect of the FD diet on parameters of the cellular oxidative 
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response in the cochlea (Figure 8A). Protein levels of the NADPH oxidase complex 
(NOX4 and p22phox) and MnSOD were analyzed by Western blotting (Figure 8B). 
Similar NOX4 protein levels were found in both mouse groups, whereas a significant 
increase in p22phox (∼1.5-fold) and MnSOD (∼1.7-fold) levels were detected in FD 
cochleae as compared to NF samples. Expression levels of genes involved in redox 
control were also analyzed by RT-qPCR in both dietary groups (Figure 8C). Reduced 
transcript levels were detected for Cat (20%), Gpx4 (30%) and Gss (15%) in the FD 
group, whilst no change was observed for Gsr, Gpx1 and Gclc between dietary groups. 
GPX proteins require GSH and generate GSSG, hence cochlear glutathione levels were 
also determined. Increased GSH (60%) and GSSG levels (50%) were measured in FD 
as compared to NF samples (Figure 8D), but these changes did not significantly alter the 
GSH/GSSG ratio (7.76 ± 0.36 vs. 8.49 ± 0.56; p=0.29). A consequence of superoxide 
metabolism is 3-nitrotyrosine (3-NT) synthesis, a metabolite that can be immunostained 
in cochlear sections (Figure 8E). FD mice showed strong immunoreactivity for 3-NT in 
the stria vascularis and the cochlear ganglion, whereas mice on the NF diet exhibited 





















Hearing loss is one of the numerous health problems that appear associated with 
micronutrient deficiencies worldwide (8-13). Their origin relies not only in 
malnutrition, but also in an inadequate nutrient density in the so-called western 
societies. Among them, low serum and blood red cell folate levels have been detected in 
several types of hearing impairment, and in some cases an association with elevated 
pHcy concentrations also has been reported (11-13). However, the underlying 
mechanisms linking folate deficit and hearing loss remain unidentified. For this reason, 
we have used a nutritional mouse model that presents both with low serum folate levels 
and hyperhomocysteinemia, thus making it a suitable model for the analysis of the 
association of these alterations and hearing loss. 
 Evaluation of the auditory response shows higher thresholds with more acute 
losses at high frequencies in FD mice, hence demonstrating a direct association between 
folate deficiency, hyperhomocysteinemia and profound hearing loss. Wave I amplitude 
decrement confirms premature impairment at the hair cell auditory nerve synapse, 
similar to that described in hearing loss associated to oxidative stress (44). 
Histopathological analyses of hearing loss in FD mice indicate that different cochlear 
populations are affected. Severe damage was evident at the organ of Corti, the spiral 
ganglion, the stria vascularis and cells of the spiral ligament. Moreover, cochlear 
damage displayed a gradient, with severe cellular loss in the basal turn, signs of damage 
including the presence of apoptotic cells in the middle turn and very light or no 
phenotype in the apex. Differences in susceptibility against ototoxic drugs by cochlear 
cell populations are exhibited for example against treatments with salicylate (45) or 
cisplatin, a chemotherapy drug, which induces a larger loss of inner hair cells in the 
cochlear base than in the apex (46).  
Folic acid is needed for Hcy remethylation, but knowledge of this part of 
cochlear metabolism was very limited, therefore requiring its characterization in control 
tissues. Most genes showed the expected expression profile for extrahepatic (high 
Mat2a expression) and non-lymphoid tissues (Adk vs. Ada expression) (47, 48). 
However, remethylation genes exhibited a specific pattern with similar expression 
levels for Mtr and Bhmt, and lower for Bhmt2, thus making the cochlea a different 
subtype among extrahepatic tissues. The corresponding proteins were also detected in 
immunoblots, commonly at very low levels. Anomalous mobilities for BHMT and 
AHCY bands, compatible with their post-translational modification, were also 
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observed, suggesting changes in their behavior and function. Large-scale mass 
spectrometry studies have detected a number of such modifications in these proteins 
(49), although their impact on BHMT and AHCY function has been scarcely explored 
(20).  
Folic acid deficiency alters the cochlear gene expression pattern, reducing the 
expression of Ahcy, Mtr and Bhmt. Reduced Bhmt expression was previously described 
in the stria vascularis of Cx30-/- null mice, however in that model of hearing loss Ahcy 
showed a modest upregulation (25). This transcriptomic study did not report additional 
changes in genes of these pathways, neither were Adk mRNA or protein levels altered in 
rats exposed to broadband noise (25, 48). Expression results correlated with those of 
immunoblots for AHCY, BHMT and ADA, whereas levels of CBS splicing forms and 
MTR signals followed different patterns. Lack of correlation between mRNA and 
protein steady-state levels are not uncommon and may be due to changes in their half-
lives. Consistent with this line of evidence, cobalamin-binding to MTR protein has been 
reported to stabilize this enzyme (50), an effect that could be expected in FD mice as an 
effort to recycle the low amounts of folate available. Altogether, changes induced by 
folic acid deficiency on Hcy metabolism are directed towards decreasing Hcy synthesis, 
(precluding the reversibility of the AHCY reaction through augmented adenosine 
utilization), reducing Hcy flux through remethylation and decreasing its use in trans-
sulfuration. In this scenario, increased adenosine elimination may limit protection 
against cochlear oxidative stress through adenosine signaling (51), although sparing the 
purine for nucleic acid and NADH/NADPH synthesis. An additional drawback for 
cochlear function may derive from the reduced flux through trans-sulfuration. CBS and 
cystathionase are able to synthesize H2S, whose protective role as cochlear vasodilator 
has been reported in noise-induced hearing loss (52). A reduced production of H2S may 
contribute to the changes detected in striatal capillaries in FD mice, in concordance with 
the decreased vessel density previously reported for Cbs(+/-) mice cochleae (24). 
Taken together the aforementioned alterations in Hcy metabolism suggest the 
presence of elevated Hcy levels in the cochleae of FD mice, an increase that is 
confirmed by detection of enhanced Hcy immunostaining along FD protein lanes. 
Increased Hcy immunostaining was previously reported in the stria vascularis of Cx30-/- 
null mice (25), also associated to reduced Bhmt expression, both data pointing towards 
BHMT as the key target for the regulation of cochlear Hcy levels. Again, these results 
suggest several mechanisms to explain cochlear dysfunction. First, homocysteinylation, 
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a post-translational modification leading to inactivation and aggregation of proteins 
with the consequent impairment of their function (53). Second, high Hcy levels, an 
independent risk factor for cardiovascular disease, as a determinant for atherosclerosis 
in the inner ear as suggested by several epidemiological reports (15-17). Third, the role 
Hcy, an agonist of N-methyl-D-aspartate receptors, in the overexcitation associated with 
hearing impairment (54, 55).   
 Oxidative stress is a condition associated with rapid ageing and which correlates 
with HL caused by noise or other noxious stimuli (44). Moreover, oxidative stress alters 
the function of several enzymes of Hcy metabolism (20, 41, 56, 57). Hence, impairment 
of Hcy metabolism in FD mice could rely on the effects of high levels of reactive 
oxygen and nitrogen species. Elimination of these damaging species is a key event to 
maintain the cell function (58-60), and requires the collective activities of a number of 
enzymes and redox buffers. The existence of oxidative stress in FD cochleae was 
revealed by: i) increased p22phox and MnSOD protein levels; ii) decreased expression 
of Cat, Gpx4 and Gss; iii) increased 3-NT levels in the stria vascularis and the spiral 
ganglion; and iv) increased GSH and GSSG levels. These results suggest increased 
ROS signaling involving the NOX complex (60), which may in turn cause the high 
level of apoptotic cells detected in the FD cochleae.  
NOX are expressed in the rat cochlea and regulated by noxious stimuli such as 
noise (61). During oxidative stress, NOX3 and NOX4 protein levels remain unchanged, 
being NADPH oxidase activator subunits, such as p22phox, the main proteins involved 
in stress response (62). Parallel to NOX activation, the increase in MnSOD suggests an 
effort to eliminate the highly reactive superoxide ion, producing peroxide with lower 
reactivity. MnSOD is a marker of neuroprotection, which is triggered as a compensatory 
mechanism against stress (63). Interestingly, Sod1-/- null mice are deaf (64). However, 
the decrease in Cat expression in FD mice suggests a putative impairment in peroxide 
elimination through this reaction, an effect that could be larger if we consider the Hcy 
inhibition of the enzyme previously reported (65). Compensatory peroxide catabolism 
can be obtained through GPX, mainly GPX1, leading to increased GSSG production 
(66). GPX1 is able to use either GSH or the γ-glutamylcysteine produced in the first 
step of GSH synthesis (66), a fact that can overcome the small reduction detected in Gss 
expression in FD mice. Additionally, expression and enzyme levels may not correlate, 
given the complex regulation of glutathione synthesis that involves among others the 
antioxidant response elements in the gene promoters, post-translational modifications 
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and feedback inhibition by GSH (67). Therefore, a combination of γ-glutamylcysteine 
accumulation, increased GSH synthesis by stabilization of GCLC protein and/or 
augmented association to GCLM (lowering its Km for glutamate and raising the Ki for 
GSH), together with elevated GSSG synthesis through GPX and imbalanced recycling 
through GSR, may explain conservation of a normal cochlear GSH/GSSG ratio in folate 
deficiency. The existence of a profound redox imbalance in the cochleae of FD mice 
was further confirmed by the detection of elevated 3-NT immunostaining. This 
metabolite is a product of peroxinitrite action, whose levels have been found augmented 
during oxidative stress in the aging ear (43).  
Oxidative stress is also known to alter methionine and folate cycles at different 
levels. Several enzymes of these pathways are susceptible to this condition given their 
need for cofactors and metals (20, 41, 57). Therefore, a reduction in folate levels 
together with the cochlear oxidative stress detected not only remodels expression and 
protein levels, but is expected to modify enzyme activities, subcellular distribution and 
oligomerization as occurs in several experimental settings (56, 68-70). In this line, the 
increased p22phox levels in FD cochleae are expected to produce NOX activation, and 
hence lead to elevated NADP+ concentrations. This metabolite is known to favor 
trimerization of methionine adenosyltransferase II reducing its affinity for methionine 
(57), an effect that in turn would guarantee the S-adenosylmethionine synthesis needed, 
among others, for epigenetic remodeling during nutritional stress. This effect may not 
be essential for FD mice receiving diets that supply enough methionine and cysteine for 
synthesizing the methyl donor and glutathione. However, it may derive from an effort to 
correct the altered methylation index resulting from the decreased cochlear AHCY 
levels that, in turn, would lead to increased S-adenosylhomocysteine concentrations and 
inhibition of transmethylations. An additional effect of impaired cochlear Hcy 
metabolism, precisely lower BHMT levels, is betaine accumulation. This increase in 
osmolyte concentrations might be beneficial to maintain the function of the thin 
cochlear basal epithelia of FD mice. 
Altogether our results confirm that the ingestion of low levels of folic acid 
induces severe impairment of cochlear Hcy metabolism, together with a profound 
oxidative misbalance, ultimately leading to hearing loss. The positive correlation 
between hyperhomocysteinemia and hearing loss in folate deficiency also suggests the 
potential of the former as a prognostic value. In addition, targeting Hcy metabolism by 
 19
nutritional interventions could be a novel pathway to achieve therapeutic protection 
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TABLE LEGENDS  
Table 1. Antibodies used in this study. The table lists the antibodies used in 
this work indicating the dilutions used for the different techniques. 
*Abbreviations used are as follows: IC-P, immunohistochemistry-paraffin; IHF, 
immunohistofluorescence; WB, western blotting. 
** tertiary extrAvidin® peroxidase-conjugated antibody (1:300 v/v; Sigma-Aldrich) 
was needed in this case. 
Table 2. Primer sequences used for Real-Time RT-PCR experiments. 
Appropriate primers for genes in the methionine cycle and related pathways were 
designed using the Program Primer Express 3.0 and the mouse gene sequences available 
in the data bank with references: NC_000068.6 (Ada); NC_000080.5 (Adk); 
NW_000085.1 (Bhmt); NC_000079.5 (Bhmt2); NC_000083 (Cbs); NT_039207 (Ahcy); 
NC_000079 (Mtr); NC_000080.5 (Mat1a); NC_000072.5 (Mat2a); NC_000077.5 
(Mat2b); NC_000072.6 (Rn18s). Base numbers indicate the location of the primer 
sequences in the corresponding mRNA; primers for Cbs and Adk were designed in 
regions common to the two splicing forms reported. The concentrations of the primers 
used for SYBR Green detection are shown in the right column. 
 
FIGURE LEGENDS  
Figure 1. Pathways involved in homocysteine metabolism and systemic 
metabolite levels. (A) Scheme of homocysteine metabolism and related pathways. 
Metabolites appear in white boxes and the enzymes listed include: adenosine deaminase 
(ADA); adenosine kinase (ADK); AdoHcy hydrolase (AHCY); betaine homocysteine 
methyltransferases (BHMTs); AdoMet-dependent methyltransferases (MTs); 
methionine adenosyltransferases (MATs); vitamin B6-dependent cystathionine β-
synthase (CBS); and vitamin B12-dependent methionine synthase (MTR). (B) Serum 
and plasma metabolite levels from all the animals in both normal (NF) and folate-
deficient (FD) groups are shown. Serum folic acid [50.85 ± 22.03 (n=10) vs. 7.46 ± 3.88 
μg/l (n=11)], plasma Hcy [5.05 ± 2.45 (n=33) vs. 14.70 ± 3.19 μM (n=69)] and plasma 
vitamin B6 levels [40.00 ± 15.71 (n=11) vs. 43.71 ± 8.74 μg/l (n=18)] were measured as 
specified in the Materials and Methods section. The figure shows the mean ± SEM for 
each group and differences were considered significant when p≤0.05; (***) p<0.0001.  
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Figure 2. Folate deficient mice show early signs of hearing loss. The auditory 
response was analyzed in mice of normal (NF) and folate-deficient (FD) groups. (A) 
Scheme of the auditory pathway. (B) Representative ABR recordings in response to 
click stimuli of NF (showing normal hearing) and FD mice (showing profound hearing 
loss). (C) ABR thresholds in response to click and tone burst stimuli in NF ( ) and FD 
() mice, after 8 weeks of diet (n=21 for each group). (D) Latency-intensity function 
for wave I of NF and FD mice showing a delay in the appearance of the wave. Data are 
shown as the mean ± SEM, (**) p<0.01; (***) p<0.001.  
Figure 3. Folate-deficient mice showed altered cochlear morphology and 
apoptotic cells. Cochlear morphology from normal (NF) and folate-deficient mice (FD) 
was studied by histochemistry and immunohistofluorescence. (A) Representative 
micrographs show basal and middle turn details of the organ of Corti in sections of NF 
(a-e; n=6) and FD mice (f-j; n=9). Phalloidin (Phal) staining of the organ of Corti 
appears in panels d, e, i and j. Stars denote the flat epithelium of the organ of Corti in 
panel g. Stars indicate the absence of hair cells. (B) Representative images and 
quantification of cell death by TUNEL assay of the organ of Corti per ROI from the 
middle turn of both groups. (C) Percentage of TUNEL-positive cells/ROI in the stria 
vascularis from the FD mice in comparison with the NF (n=6 mice studied per 
experimental group). IHC, inner hair cells; OHC, outer hair cells; SV, scala vestibulae; 
ST, scala tympani; SM, scala media. Scale bars: 500 µm (a,f); 50 µm (d,e,i,j) and 25 µm 
(b,c,g,h).  
Figure 4. Folate-deficient mice showed altered cochlear cytoarchitecture. 
Sections of cochleae from mice on normal (A-H; n=6) or folate-deficient (J-Q; n=9) 
diets were stained with Masson's Trichrome, H&E or used for immunofluorescence. 
Basal and middle turn details of the ligament (Spl), cochlear ganglion (CG) and stria 
vascularis (StV) are shown. Immunohistochemistry results of the cochlear ganglion 
neurons labeled with myelin protein zero are shown at higher magnification in the insets 
to panels D, E, M and N. Details of the stria vascularis immunolabeled with Kir4.1 
(Kir4.1) are included as insets to panels G, H, P and Q. Arrows indicate the absence of 
cells (J, M). Scale bars: 25 µm (A-H, J-Q and insets to G, H, P, Q); 10 µm (insets to D, 
E, M, N). Panel C depicts a scheme of the cochlea where basal and middle turns are 
indicated by squares. The intensity of the signals (0 to 256 grey scale) was quantified 
for normal (NF; n=4) and folate-deficient (FD; n=6) samples and the results are shown 
as the mean ± SEM in F, I, L, O, R histograms. (**) p<0.01 and (***) p<0.001.  
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Figure 5. Cochlear homocysteine metabolism in control mice. Samples of 
cochleae from mice receiving a normal folate diet were used to characterize Hcy 
metabolism and related reactions. (A) Total cochlear RNA was used to analyze 
expression levels of the genes of interest by real-time RT-PCR. Data were normalized 
using the Rn18s gene as reference and the results were referred to Mat1a levels set 
arbitrarily to 10 for graphical purposes (n=6). (B-D) Total cochlear proteins from wild 
type and Bhmt-/- null mice (200 μg), as well as cytosols from hepatoma H35 cells (3 
μg), were used to verify the specificity of the bands detected on western blots. 
Membranes were incubated with: (B) rabbit anti-BHMT (71) and mouse anti-tubulin; 
(C) preimmune serum; and (D) goat anti-AHCY. The size of the prestained markers is 
indicated on the left side of the blots. 
Figure 6. Folate deficiency alters expression of genes involved in Hcy 
metabolism. Total cochlear RNA of mice on normal (NF, n=11) or folate deficient (FD, 
n=12) diets was used to analyze expression levels of the genes of interest by real-time 
RT-PCR using the Rn18s gene as reference. The results are shown as the mean ± SEM 
of determinations made in triplicate for each animal sample. Statistical analysis by 
Student´s t-test was carried out using GraphPad Prism and data considered significant 
when p≤ 0.05 (*). 
Figure 7. Effects of folate deficiency on cochlear protein levels of enzymes 
involved in homocysteine metabolism. Total cochlear protein (200 μg/lane) of animals 
in normal (NF; n=11) and folate-deficient (FD; n=20) diets were analyzed by western 
blot using the following antibodies: (A) anti-AHCY; (B) anti-CBS; (C) anti-BHMT; (D) 
anti-MTR; (E) anti-ADK; and (F) anti-ADA. Representative immunoblots for each 
antibody are shown, together with quantifications (mean ± SEM) carried out with 
ImageJ software, normalized using tubulin as the loading control. For graphical 
purposes, the mean of the NF group ratio was considered 100% in each case. Statistical 
analysis was carried out using Student’s t-test and differences were consider significant 
when p≤0.05 (*). (G) Representative image of anti-homocysteine western blot on NF 
and FD mice and its densitometric analysis. Mean data of the NF group are presented as 
100% for graphical purposes, being the ratios 3.92 ± 0.80 (NF; n=4) and 6.28 ± 1.06 
(FD; n=5). 
 Figure 8. Folate deficient mice showed oxidative imbalance in the cochlea. 
Cochleae from mice on normal (NF) and folate-deficient (FD) diets were used to 
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evaluate several oxidative stress markers. (A) Schematic representation of the role of 
the oxidative stress markers analyzed in this work. (B) Representative immunoblots for 
NADPH oxidase (NOX4; n=3 NF and n=4 FD), MnSOD (n=6 NF and n=9 FD) and 
p22phox (n=5 NF and n=9 FD). The histograms show the mean ± SEM of densitometric 
scanning results after normalization using β-actin levels. (C) Expression levels of Cat, 
Gpx1, GPx4, Gsr, Gclc and Gss evaluated by real-time RT-PCR using Rplp0 as 
reference. (D) Evaluation of cochlear oxidized (GSSG) and reduced (GSH) glutathione 
levels (n=6 mice per group). (E) Representative images of 3-nitrotyrosine (3-NT) levels 
detected by immunohistochemistry in the stria vascularis (StV; a,b) and cochlear 
ganglion (SG; c,d) of NF (a,c; n=3) and FD (b,d; n=6) mice. (e) Quantification of the 3-
NT signal is shown in the histograms as the mean ± SEM. Statistical evaluation of the 







Table 1.   




Chicken anti-Myelin P0 Novus Biologicals 
(NB100-1607) 


















IgG donkey anti-rabbit 
Alexa Fluor 488 
Molecular Probes 
(A21206) 1:400 IHF 








Mouse anti-CBS Abnova (H00000875-A01) 1:2500 
IgG sheep anti-mouse 
HRP conjugated 
GE Healthcare 
(NA931) 1:20000 WB 
Rabbit anti-BHMT González et al. [1] 1:5000 





Rabbit anti-ADK Abcam (ab88903) 1:500 





Rabbit anti-Hcy Chemicon-Millipore 
(AB5512) 





Rabbit anti-p22phox  Santa Cruz (sc-20781) 1:500 





Rabbit anti-MnSOD Upstate Millipore (06-984) 1:2500 





Goat anti-AHCY Santa Cruz (sc-66759) 1:1000 





Goat anti-MTR Abnova (PAB6022) 1:250 





Goat anti-ADA Santa Cruz (sc-7451) 1:2500 
IgG donkey anti-goat 
HRP conjugated 
Santa-Cruz 
(sc-2020) 1:10000 WB 
Goat anti-NOX4  Santa Cruz (sc-21860) 1:500 






Table 2.  
Gene Bases Forward primer (5’-3’) Bases Reverse primer (5’-3’) nM 
Ada 641-663 GGGATGAGACCATTGAAGGAAGT 709-689 TCTTTACTGCGCCCTCATAGG 300 
Adk 883-903 AGAGGCAGAGGACCGTGATCT 946-925 TCATTCTCTGCAGCCACTATGG 300 
Bhmt 672-692 CAGAATTCCCCTTTGGATTGG 742-721 GGCCTCTCTGGCATATTTTTGA 300 
Bhmt2 143-166 CTCCAGAAGCAGTGGTAGAACATC 217-198 CATCAGCTCCCGCTCTCAAG 300 
Cbs 1274-1292 GCAGCGCTGTGTGGTCATC 1337-1312 GTCACTCAGGAACTTGGACATGTAGT 300 
Ahcy 1531-1554 TCGAAGTGTCCAATGTTACAGACA 1592-1575 CTTGGCCGGCACTTTGAG 300 
Mtr 2006-2026 CGCGATCAAGTTTGGTATGGA 2080-2057 TCCTTGTGGATAGCATCATACACA 300 
Mat1a 1285-1307 GGTGTTATTGTCAGGGACTTGGA 1347-1329 GCCGTAGCACGCAGTCTTC 300 
Mat2a 1057-1079 GGAGGGTTCTTGTTCAGGTCTCT 1123-1102 TGGAAAATGGAGATCGACAATG 300 
Mat2b 134-153 GCTGGTGGAGGAGGAAGTGA 192-173 CAGTGGCACCGGTAATGAGA 300 
Rn18s 1645-1666 CCAGTAAGTGCGGGTCATAAGC 1716-1737 CCGATTGGATGGTTTAGTGAGG 100 
 
 









